German pharmaceuticals firm Merck KGaA is no longer delivering the cancer drug Erbitux to Greek hospitals, a spokesman said on Saturday.
Publicly-owned hospitals in some countries worst hit by the eurozone debt crisis had been struggling to pay their bills, Merck?s chief financial officer, Matthias Zachert, was quoted as saying by German paper Boersen-Zeitung in an interview on the weekend.
He said however that the only country where Merck had stopped deliveries was Greece.
?It only affects Greece, where we have been faced with many problems. It?s just the one product,? he told the paper.
A spokesman for the company told Reuters that the drug concerned was Erbitux and that Greeks can still purchase it from pharmacies. [Reuters]